Response to crizotinib and clinical outcome in ALK-rearranged pulmonary pleomorphic carcinoma

Yasushi Murakami, Hideo Saka, Masahide Oki

研究成果: ジャーナルへの寄稿 › Letter › 査読

本文言語	英語
ページ（範囲）	e28-e29
ジャーナル	Journal of Thoracic Oncology
巻	10
号	5
DOI	https://doi.org/10.1097/JTO.0000000000000450
出版ステータス	出版済み - 30-05-2015
外部発表	はい

All Science Journal Classification (ASJC) codes

@article{c7dda945b9f04a20bf4fd6bfa44d5cd8,

title = "Response to crizotinib and clinical outcome in ALK-rearranged pulmonary pleomorphic carcinoma",

author = "Yasushi Murakami and Hideo Saka and Masahide Oki",

year = "2015",

month = may,

day = "30",

doi = "10.1097/JTO.0000000000000450",

language = "English",

volume = "10",

pages = "e28--e29",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Response to crizotinib and clinical outcome in ALK-rearranged pulmonary pleomorphic carcinoma

AU - Murakami, Yasushi

AU - Saka, Hideo

AU - Oki, Masahide

PY - 2015/5/30

Y1 - 2015/5/30

UR - http://www.scopus.com/inward/record.url?scp=84938245192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938245192&partnerID=8YFLogxK

U2 - 10.1097/JTO.0000000000000450

DO - 10.1097/JTO.0000000000000450

M3 - Letter

C2 - 25898961

AN - SCOPUS:84938245192

SN - 1556-0864

VL - 10

SP - e28-e29

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 5

ER -